1, Ma Yinglong is a Chinese time-honored enterprise recognized by the Ministry of Internal Trade, and was established in 1582.

2. After sustained, rapid and healthy development, Ma Yinglong has become a professional, multi-functional and international pharmaceutical listed company involving pharmaceutical manufacturing, pharmaceutical research and development, pharmaceutical wholesale and retail, chain hospitals and other fields.

3. Over the past ten years, Ma Yinglong Pharmaceutical has carried out fruitful property right system reform, formed diversified equity structure and relatively perfect corporate governance structure, and continuously introduced advanced management methods, management mechanisms and concepts.

4. Ma Yinglong Pharmaceutical adheres to the brand management strategy, takes the market as the guidance, strengthens the core competitiveness, integrates social resources with the brand as the link, meets customer needs, cultivates customer loyalty, and keeps pace with the times under the banner of the brand.

5, adhere to the strategy of capital management, based on industrial management, and take capital management as a means of extraordinary development; Adhere to the alliance management strategy and establish win-win alliance and cooperation relations with upstream and downstream partners and domestic and foreign partners.

6. The modern management consciousness and the cultural tradition formed by Ma Yinglong pharmaceutical industry for more than 400 years have formed an interactive effect, which has aroused the vitality of Ma Yinglong, and various economic indicators have been rising year by year, maintaining a positive growth of more than double digits for ten consecutive years.

Extended data

1. Ma Yinglong Pharmaceutical Co., Ltd. has developed into a professional and multifunctional pharmaceutical group listed company involving drug production, drug research and development, and drug wholesale and retail, with 10 subsidiaries.

2. In 2004, Ma Yinglong's stock was successfully listed on the Shanghai Stock Exchange, which achieved the goal of capital securitization in Ma Yinglong, and marked that Ma Yinglong entered a new historical development stage.

3. The listing of Ma Yinglong stock further enhanced the core competitiveness of Ma Yinglong Pharmaceutical, enhanced the brand image of Ma Yinglong Pharmaceutical, and provided a channel for the sustained and rapid development of Ma Yinglong Pharmaceutical and a platform for standardized and healthy operation.

Baidu Encyclopedia-Ma Yinglong